Semilobar holoprosencephaly

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:220386OMIM:301043Q04.2
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Semilobar holoprosencephaly is a congenital brain malformation that represents an intermediate form of holoprosencephaly (HPE), a spectrum of defects resulting from incomplete division of the embryonic forebrain (prosencephalon) into two distinct cerebral hemispheres. In semilobar holoprosencephaly, the brain shows partial separation of the hemispheres posteriorly, but the frontal and parietal lobes remain fused, with incomplete formation of the interhemispheric fissure and partial or absent separation of the deep brain structures such as the thalami. The corpus callosum is typically absent or severely underdeveloped. This form is less severe than alobar holoprosencephaly (where there is no hemispheric division) but more severe than lobar holoprosencephaly. The condition primarily affects the central nervous system but frequently involves craniofacial structures as well. Key clinical features include intellectual disability of variable severity, seizures, motor impairment, and developmental delay. Craniofacial anomalies may include midface hypoplasia, cleft lip and/or palate, hypotelorism (closely spaced eyes), a flat nasal bridge, or a single central incisor. In some cases, more severe facial features such as cyclopia or proboscis may occur, though these are more commonly associated with the alobar form. Endocrine dysfunction, particularly diabetes insipidus and growth hormone deficiency related to hypothalamic-pituitary axis abnormalities, is also frequently observed. Feeding difficulties and temperature regulation problems may occur in infancy. Holoprosencephaly, including the semilobar form, can result from chromosomal abnormalities (such as trisomy 13), mutations in genes including SHH, ZIC2, SIX3, and TGIF1, or environmental factors such as maternal diabetes. There is no cure for semilobar holoprosencephaly. Treatment is supportive and symptomatic, focusing on seizure management with antiepileptic medications, hormone replacement therapy for endocrine deficiencies, surgical correction of craniofacial anomalies when appropriate, physical and occupational therapy, and nutritional support. Prognosis varies considerably depending on the degree of brain malformation and associated anomalies, with some individuals surviving into childhood or beyond with significant supportive care.

Clinical phenotype terms— hover any for plain English:

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Semilobar holoprosencephaly.

View clinical trials →

No actively recruiting trials found for Semilobar holoprosencephaly at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Semilobar holoprosencephaly community →

No specialists are currently listed for Semilobar holoprosencephaly.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Semilobar holoprosencephaly.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Semilobar holoprosencephalyForum →

No community posts yet. Be the first to share your experience with Semilobar holoprosencephaly.

Start the conversation →

Latest news about Semilobar holoprosencephaly

No recent news articles for Semilobar holoprosencephaly.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Semilobar holoprosencephaly

What is Semilobar holoprosencephaly?

Semilobar holoprosencephaly is a congenital brain malformation that represents an intermediate form of holoprosencephaly (HPE), a spectrum of defects resulting from incomplete division of the embryonic forebrain (prosencephalon) into two distinct cerebral hemispheres. In semilobar holoprosencephaly, the brain shows partial separation of the hemispheres posteriorly, but the frontal and parietal lobes remain fused, with incomplete formation of the interhemispheric fissure and partial or absent separation of the deep brain structures such as the thalami. The corpus callosum is typically absent or

At what age does Semilobar holoprosencephaly typically begin?

Typical onset of Semilobar holoprosencephaly is neonatal. Age of onset can vary across affected individuals.